LDLR and Alzheimer disease: In summary, we propose that the reduction in levels of LDLR and other ApoE-binding receptors at the plasma membrane (Figure 4) leads to impaired lipid metabolism and cellular signaling and predisposes these neurons to disorders of aging and AD.